Structural aspects of nucleotide ligand binding by a bacterial 2H phosphoesterase by Myllykoski, Matti & Kursula, Petri
RESEARCH ARTICLE
Structural aspects of nucleotide ligand
binding by a bacterial 2H phosphoesterase
Matti Myllykoski1, Petri Kursula1,2*
1 Faculty of Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Oulu, Finland,
2 Department of Biomedicine, University of Bergen, Bergen, Norway
* petri.kursula@uib.no
Abstract
The 2H phosphoesterase family contains enzymes with two His-X-Ser/Thr motifs in the
active site. 2H enzymes are found in all kingdoms of life, sharing little sequence identity
despite the conserved overall fold and active site. For many 2H enzymes, the physiological
function is unknown. Here, we studied the structure of the 2H family member LigT from
Escherichia coli both in the apo form and complexed with different active-site ligands, includ-
ing ATP, 20-AMP, 30-AMP, phosphate, and NADP+. Comparisons to the well-characterized
vertebrate myelin enzyme 20,30-cyclic nucleotide 30-phosphodiesterase (CNPase) highlight
specific features of the catalytic cycle and substrate recognition in both enzymes. The role
played by the helix α7, unique to CNPases within the 2H family, is apparently taken over by
Arg130 in the bacterial enzyme. Other residues and loops lining the active site groove are
likely to be important for RNA substrate binding. We visualized conformational changes
related to ligand binding, as well as the position of the nucleophilic water molecule. We also
present a low-resolution model of E. coli LigT bound to tRNA in solution, and provide a
model for RNA binding by LigT, involving flexible loops lining the active site cavity. Taken
together, our results both aid in understanding the common features of 2H family enzymes
and help highlight the distinct features in the 2H family members, which must result in differ-
ent reaction mechanisms. Unique aspects in different 2H family members can be observed
in ligand recognition and binding, and in the coordination of the nucleophilic water molecule
and the reactive phosphate moiety.
Introduction
The 2H phosphoesterase superfamily is an ancient group of proteins and protein domains
characterized by a common fold and a few conserved active site residues [1,2]. Various cata-
lytic activities have been assigned for the 2H enzymes: hydrolysis of a 20,30-cyclic phosphate, in
either nucleotides or 30-ends of RNA molecules, into 20-phosphate [3–5], hydrolysis of ADP-
ribose 100,200-cyclic phosphates into ADP-ribose 100-phosphate [6–8], generation and/or cleav-
age of 20-50-linkages between nucleotides or RNA molecules, such as tRNA halves [3,9–13],
and 30-50 exonucleolytic removal of terminal uridine nucleotides from snRNA with the simul-
taneous generation of 20,30-cyclic phosphates at the terminus [14]. The structurally best-
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characterized 2H enzyme is the mammalian myelin enzyme 20,30-cyclic nucleotide 30-phos-
phodiesterase (CNPase) [15–19], but even for this enzyme, the biological function remains
enigmatic [5].
E. coli LigT is a 20-kDa protein that exhibits 20,30-cyclic nucleotide 30-phosphodiesterase
and 20-50-ligase/phosphodiesterase activities [3,9], but the biological function of the enzyme is
unknown. It is potentially a source of 20-50 oligoadenylates (2-5A) and similar compunds with
20-50-linkage detected in E. coli [20]. A genomic knockout of LigT in E. coli did not obviously
affect cellular growth or viability in laboratory conditions, while LigT overexpression produced
a phenotype sensitive to elevated temperature [9]. A LigT orthologue in Deinococcus radiodur-
ans was massively upregulated after acute irradiation, and it was speculated to function in the
handling of damaged RNA species [21].
In a recent study, E. coli LigT was crystallized, and its structure was refined in complex with
the in vitro reaction product 20-AMP [22]. We extend the previous study here, providing high-
resolution crystallographic data and different active-site ligand complexes. Comparisons to the
apo form of the enzyme determined in the current work allow the highlighting of conforma-
tional changes and binding determinants of the reactive species. Based on further comparisons
to mouse CNPase, we also modelled the substrate complex of LigT and discuss unique features
of each protein. An extended binding surface for RNA substrates is also identified, which pos-
sibly involves flexible loops of the 2H family. All in all, we provide novel data on the structure-
function relationships in a bacterial 2H enzyme, which can be used to understand the common
and divergent properties of enzymes in the entire 2H superfamily.
Results and discussion
Overall structure
The structure of the putative tRNA ligase LigT from E. coli was determined by X-ray crystallog-
raphy in the apo form. In addition, a number of LigT complex structures with active-site
ligands were solved, hence significantly extending the earlier results on the LigT structure,
which was only available as a complex with the reaction product 20-AMP [22]. Intriguingly, a
total of five different crystal forms were observed in this study, which also highlights the flexi-
ble properties of the enzyme.
The LigT structure presents a typical 2H phosphoesterase fold, in which the catalytic resi-
dues reside at the beginning of strands β2 and β6 (Fig 1A). As in other 2H family members, the
active site has 2-fold symmetry; this symmetry also includes the 4 water molecules at the bot-
tom of the active site, connecting the active-site β strands through water-mediated hydrogen
bonds (Fig 1B). These water molecules coordinate the substrate/product throughout the reac-
tion in CNPase [17,18], and they are likely to play a similar role in LigT and other 2H phos-
phoesterases. The strict conservation of the active-site water structure between 2H enzymes is
remarkable, taking into account the amino acid sequence identity of slightly above 10%
between CNPase and LigT.
Liganded complexes
For an insight into the active-site properties and catalytic mechanism, we co-crystallized LigT
with different nucleotide compounds in the active site (Table 1, Fig 2), including substrates,
products, and other compounds. In addition to the presumed obvious substrates and products,
we also used other nucleotide compounds in an attempt to screen LigT crystallographically for
nucleotide-like ligand-binding properties. This was considered of interest, as open questions
remain related to the physiological function of both LigT and many 2H family enzymes in
2H enzyme active site structure
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general. All structures had more than one protein chain in the asymmetric unit, and in general,
the one with best-defined electron density for ligands was used in the analyses below.
Previously, LigT has been crystallized with the reaction product 20-AMP [22]. We also
observed such a complex after cocrystallization with 20,30-cAMP (Fig 2A). The binding mode
is similar to that seen before, and the 20-AMP ligand is well defined in one of the two LigT
monomers, while the occupancy in the other monomer is low. Binding involves aromatic
stacking of the nucleotide base against Phe48 and a C-H. . .π interaction between the ribose
ring and Phe8. In addition to the catalytic residues, Arg130 plays a key role in coordinating the
phospho moiety of the product. Considering reaction geometry, a water molecule coordinated
by His125 in the apo structure can now be designated as the nucleophilic water (Fig 2A), anal-
ogously to CNPase. The complex also proves that LigT has CNPase activity towards 20,30-cyclic
mononucleotides, since the reaction product is bound in the crystals grown in the presence of
the substrate.
A possible role for 20,30-cyclic nucleotides in mammalian systems has been lately discovered
[23], but their importance in prokaryotic systems is not known. However, 20,30-cyclic cytidine
and uridine monophosphate were recently detected in the extracts of Pseudomonas fluorescens
[24], and several bacterial phosphodiesterases that cleave 20,30-cyclic nucleotides have been
described over the years [25,26]. Whether LigT activity plays a role in the metabolism of such
compounds in vivo, remains to be studied.
Another product analogue of the reaction catalysed by LigT, NADP+, was also trapped in
the active site, being well defined in electron density (Fig 2B). In the NADP+ complex, there
are 4 monomers in the asymmetric unit, and the nicotinamide end of the ligand binds to each
of them differently, having different conformations or being disordered—depending on crystal
contacts. The adenosine 20,50-bisphosphate moiety in each monomer binds identically, how-
ever, and in a mode highly similar to that seen in 20-AMP. The 50-phosphate mimics the next
phosphodiester in an RNA molecule, and it can be used to deduce further binding determi-
nants for RNA substrates. This phosphate moiety is bound by Arg6 from the N-terminal
strand β1 in the crystal structure, and it is likely that this residue plays a direct role in RNA
Fig 1. The structure of E. coli LigT. A. Overall structure of LigT. Secondary structure elements and the N and C termini are labeled,
and the two active site HxT motif side chains are also shown. B. Stereo view of the organization and conservation of the active site
between LigT (white) and mouse CNPase (blue) [18]. The four water molecules between strands 2 and 6 are conserved (LigT, red;
CNPase, blue). The nucleophilic water molecule in LigT (green) is coordinated by His125 and Arg130, while the corresponding water
molecule in CNPase (magenta) interacts with the N terminus of helix 7 (right) and the catalytic histidine.
doi:10.1371/journal.pone.0170355.g001
2H enzyme active site structure
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Table 1. Crystallographic data collection and structure refinement statistics.
Ligand none phosphate (tRNA) ATP 2’-AMP 3’-AMP ATP NADP+
Data collection statistics
Space group P21 P1 C2 P4212 P21 C2 C2
Cell parameters
a (Å) 63.39 54.73 101.95 108.07 63.41 102.15 86.74
b (Å) 88.32 63.52 73.33 108.07 88.35 73.47 91.62
c (Å) 73.84 67.37 77.49 72.64 73.97 77.61 120.61
α (˚) 90 106.26 90 90 90 90 90
β (˚) 115.01 106.14 128.54 90 114.95 128.34 102.32
γ (˚) 90 103.06 90 90 90 90 90
No. of molecules in ASU 4 4 2 2 4 2 4
Wavelength (Å) 1.03 1.04 1.04 1.04 1.04 1.04 1.03
High resolution (Å) 2.10 2.80 2.10 2.46 2.75 1.80 1.70
High-resolution shell (Å) 2.15–2.10 2.88–2.80 2.15–2.10 2.52–2.46 2.82–2.75 1.85–1.80 1.74–1.70
Unique reflections 43063 (3154) 18651 (1460) 26124 (1890) 15451 (613) 19216 (1356) 41617 (3088) 100969 (7397)
Multiplicity 3.81 (3.83) 2.21 (2.20) 3.81 (3.78) 6.60 (2.58) 3.80 (3.76) 3.38 (3.33) 3.80 (3.86)
Completeness (%) 99.6 (99.8) 95.7 (94.3) 99.2 (99.2) 95.4 (52.4) 99.3 (97.8) 99.2 (99.5) 99.8 (99.8)
Rmerge 0.076 (0.918) 0.126 (0.942) 0.075 (0.829) 0.079 (0.621) 0.092 (0.804) 0.047 (1.061) 0.053 (1.043)
Rmeas 0.089 (1.067) 0.171 (1.270) 0.088 (0.967) 0.086 (0.747) 0.107 (0.939) 0.056 (1.258) 0.061 (1.211)
<I/σ(I)> 11.93 (1.30) 7.21 (1.02) 14.16 (1.65) 18.01 (1.51) 14.11 (1.76) 15.47 (1.31) 13.92 (1.23)
CC½ (%) 99.8 (58.1) 97.8 (41.3) 99.8 (64.8) 99.9 (71.2) 99.6 (62.9) 99.9 (50.8) 99.9 (61.9)
Wilson B (Å2) 35.6 42.6 32.0 47.4 46.1 28.8 27.3
Refinement statistics
Resolution range (Å) 36.60–2.10 22.96–2.80 23.37–2.10 29.04–2.46 28.75–2.75 19.70–1.8 117.84–1.70
High-resolution shell (Å) 2.15–2.10 2.88–2.80 2.15–2.10 2.54–2.46 2.82–2.75 1.85–1.80 1.74–1.70
Reflections in the working set 40878 (2698) 16784 (1279) 24120 (1685) 13888 (728) 17272 (1183) 39641 (2810) 98860 (6928)
Reflections in the test set 2153 (142) 1859 (144) 1997 (141) 1544 (78) 1922 (126) 1975 (147) 1998 (139)
R value (%) 17.74 (27.52) 21.77 (34.36) 20.18 (26.83) 19.70 (34.24) 21.17 (31.25) 17.06 (29.33) 18.34 (38.32)
Rfree value (%) 22.67 (29.43) 25.80 (40.78) 24.76 (32.97) 25.28 (39.44) 25.87 (38.53) 20.35 (34.02) 21.26 (41.66)
RMSD bond length (Å) 0.004 0.003 0.008 0.005 0.003 0.019 0.007
RMSD angle (˚) 0.981 0.705 1.148 0.937 0.830 1.834 1.321
Atoms in ASU* 11652 (5579) 5490 2949 5771 (2854) 5475 3322 (12) 7048
Protein atoms in ASU 5561 5444 2721 2807 5449 2902 6059
Ligand atoms in ASU 3 25 31 47 23 99 351
Water molecules in ASU 509 21 197 63 3 279 638
Mean B value (Å2) 54.9 60.80 36.45 64.03 48.21 42.91 39.45
Ramachandran plot
Favoured regions (%) 99.26 99.40 97.88 98.25 97.74 99.72 98.63
Allowed regions (%) 0.59 0.60 2.12 1.75 1.36 0.28 1.09
Outlier residues (%) 0.15 0 0 0 0.90 0 0.27
Clashscore 2.42 3.93 5.09 2.46 5.02 12.07 8.46
Rotamer outliers (%) 0.87 1.79 6.07 3.03 0.89 1.33 2.23
PDB entry 5ldi 5ldj 5ldk 5ldm 5ldo 5ldp 5ldq
* Number of riding hydrogen atoms is shown in parentheses.
doi:10.1371/journal.pone.0170355.t001
2H enzyme active site structure
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substrate binding also. An additional NADP+ fragment is seen stacked on top of Trp82 in one
monomer.
We also cocrystallized the enzyme with ATP and 30-AMP, which are neither substrates nor
products. The fact that they bind the active site can imply that they may be weak inhibitors,
and it can be taken as evidence of a general propensity to bind nucleotides in the active site.
The LigT orthologue protein PF0027 from Pyrococcus furiosus was shown to require a GTP
cofactor for the RNA ligation reaction [3], while for the E. coli enzyme, such a cofactor has not
been reported. Although we attempted crystallization in the presence of GTP as with ATP, no
corresponding GTP electron density was found in the resulting crystals (data not shown). Two
similar datasets were collected with ATP, one of which has one ATP bound to only one of the
2 monomers in the asymmetric unit. This ATP molecule probably has a partial occupancy
and/or some degree of flexibility, as evidenced by residual difference electron density. The
major conformation was built in the structure. The other complex has three ATP molecules
for two monomers; the space group remains the same. The reason for this fortuituous ambigu-
ity is unknown. In addition to the ligand in both active sites (Fig 2B), another ATP in the latter
crystal form is bound in the vicinity of it in one monomer; this ATP is also involved in crystal
contacts. The binding of this second ATP is a strong indication of a propensity for binding fur-
ther nucleotides in the active site vicinity by E. coli LigT. Residues interacting with the second
ATP include Phe159 and Arg6. Again, the α-50-phosphate of the active-site ATP is in the same
location as the corresponding phosphate in NADP+, and it is similarly coordinated by Arg6,
highlighting putative RNA recognition features extending from the active site.
Fig 2. Crystal structures of LigT complexed with different active-site ligands. A. Comparison between apo
LigT (white) and the 20-AMP complex (blue). Interactions of the ligand phosphate group are shown as orange
dashed lines and those of the nucleophilic water molecule (green) in the apo structure as green dashed lines. B.
Complexes with NADP+ (light brown) and ATP (green). Note the stacking of the NADP+ nicotinamide ring
against Phe159 and the coordination of the 50-phosphate in both ligands by Arg6. C. Binding modes of 20-AMP
(blue) and 30-AMP (light blue). The same recognition elements are at play, but especially the ribose ring binds
differently. D. Cocrystallization with tRNA resulted in a complex with two phosphate ions, one in the active site
and the other one in a nearby pocket surrounded by Arg residues.
doi:10.1371/journal.pone.0170355.g002
2H enzyme active site structure
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As far as the 30-AMP experiment is concerned, one of the 4 monomers in the asymmetric
unit has a bound 30-AMP molecule, with the phosphate group in the same position as in the
20-AMP product complex. Binding of the ligand to the remaining monomers is apparently pre-
vented by crystal contacts. The conformation of 30-AMP differs slightly from that observed for
20-AMP, but the essential recognition features remain the same; stacking of the base against
Phe48, binding of the phosphate to the two HxTx motifs in the active site, and C-H. . .π inter-
action of the sugar ring against Phe8 (Fig 2C). As incubation with 20,30-cAMP resulted in 20-
AMP, the 30-AMP complex is irrelevant for the reaction mechanism. To generate 30-AMP in
the LigT reaction, the nucleophilic water should attack from the opposite side.
In addition, attempts to cocrystallize LigT with tRNA resulted in a structure with apparent
phosphate ions bound to the active site; these probably originated as impurities in the tRNA
preparation. Two distinct PO4-binding sites are observed in the active site, on both sides of
Arg130 (Fig 2D). Their locations could correspond to binding sites for phosphomoieties in a
bound RNA substrate. One of the phosphates lies in the active site, while the second is in a
nearby cavity, close to Arg35. The density for the second phosphate molecule was strongest in
monomer D, and it was not built into the other three monomers in the model, as the electron
density suggested only partial occupancy.
Substrate and product binding
The crystal structure of LigT with 20-AMP was superimposed on the corresponding complex
of CNPase, in order to distinguish common and divergent ligand binding determinants in 2H
enzymes. The binding mode of the reaction product is very similar in both enzymes, and the
base and sugar moieties make similar interactions. While in CNPase, the N terminus of helix
α7 is important in coordinating the reaction product [17], Arg130 is an important residue for
binding the corresponding phosphate group in LigT (Fig 3A).
As the crystals obtained in the presence of substrate resulted in the structure of a product
complex, we also modeled the likely substrate complex of LigT and 20,30-cAMP, based on our
earlier liganded complexes of CNPase [16–18], coupled to manual docking and energy mini-
mization. The predicted binding mode and interactions are very similar to those seen in
Fig 3. Product and substrate binding. A. Comparison of the binding modes of 20-AMP in LigT (white) and
mouse CNPase (blue). Interactions of the phosphate are indicated by dashed lines; note the binding of the
phosphate by Arg130 in LigT, while the phosphate is coordinated to the helix α7 N terminus in CNPase. The
other interactions are essentially identical. B. Modelling of the substrate complex of LigT. 20,30-cAMP and the
nucleophilic water were modeled into the LigT active site based on CNPase structures and the 20-AMP
binding mode to LigT. Polar interactions are shown by yellow dashed lines, and the activation of the water
molecule by His125 by an orange dashed line. The direction of nucleophilic attack is shown by the green
dashed line. His43 (behind) donates a proton to the leaving group, the ribose 30-oxygen.
doi:10.1371/journal.pone.0170355.g003
2H enzyme active site structure
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CNPase. Compared to the product binding mode, His125 is not directly interacting with the
substrate, but coordinates the nucleophilic water instead (Fig 3B).
Within the active site region, the presence of helix α7 in CNPase is a major difference
(Fig 4A). The CNPase-specific helix α7 is missing in LigT, as predicted based on sequence
analysis and a structure-based alignment (Fig 4B). CNPase is the only known 2H phosphoes-
terase family protein with helix α7 and also the only one, for which the catalytic mechanism
has been structurally characterized in detail [5,15–17,19].
Binding to nucleotides in solution
In light of the X-ray crystallographic results, indicating propensity for binding of different
nucleotide compunds, we probed ligand compounds also for binding to LigT in solution, in
order to clarify whether the observed ligand complexes were possibly artifacts of the crystalli-
zation environment. ITC was carried out for 20- and 30-AMP, ATP, and NADP+ (S1 Fig). The
dissociation constants observed for these compounds were 140, 180, 70, and 40 μM, respec-
tively. In light of the Km values of mouse CNPase towards 2
0,30-cyclic NADP+ of around
500 μM [27], the Kd values determined for LigT are similar and indicate binding of the studied
nucleotide compounds to LigT also in solution, in addition to the crystal lattice.
Conformational flexibility
The active site is surrounded by several loops, which might provide flexibility in substrate
binding. The α5-β6 loop, which emerges from helix α5 and leads to the strand β6 that contains
one half of the catalytic residues, is disordered in many structures, but can be resolved in
selected monomers in the different crystal forms. In mouse CNPase, this loop corresponds to
the mobile loop α6-β5, which may play a role in CNPase interaction with larger substrates.
Other flexible loops close to the LigT active site include the C-terminal hairpin loop β8-β9 and
the loop connecting strands β4 and β5.
The LigT ligand complexes highlight mobility of the LigT loops and possible RNA-interacting
residues close to the active site. In different crystal forms, the active-site loops can be observed in
Fig 4. Comparison of CNPase and LigT. A. Structural superposition of E. coli LigT (white) and mouse
CNPase (blue). Specifically note the unique helix α7 (dark blue) in CNPase, lining the CNPase active site, and
blocking access of nucleophiles larger than water. B. Structure-based sequence alignment of LigT (Ec) and
CNPase (Mm).
doi:10.1371/journal.pone.0170355.g004
2H enzyme active site structure
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slightly different conformations (Fig 5A), and especially residues Arg6 and Arg35 take different
conformations depending on the bound ligand, further implying their role in phosphomoiety
recognition. In a ligand-free active site, also Phe48 is seen to take a conformation distinct from
that seen in ligand complexes. Hence, as opposed to CNPase, in which the active site is to a large
extent pre-organized for substrate binding [16,17], LigT shows more flexibility.
To get further information on the flexibility of the loops, we performed a search for the
closest 2H structural homologues (Fig 5B). The Salami structural homology search detected 11
homologous proteins from the PDB, the best hit representing the previous LigT structure. Ver-
tebrate CNPases were not included in this list, which had 2H proteins from bacteria, viruses,
and plants; many of these are annotated as 20-50 RNA ligases or phosphoesterases. Superposi-
tion of the structures indicated highly similar folding, despite sequence identities as low as 7%,
and the largest differences were in the loops mentioned above. This result further highlights
the flexibility of the active-site vicinal loops and suggests they may be important in RNA sub-
strate recognition in the entire 2H enzyme family. Visualization of the temperature factors in
the LigT crystal structure is in line with this loop flexibility (Fig 5C). The loop corresponding
to the α5-β6 loop is also very flexible in mouse CNPase (Fig 5D).
Fig 5. Flexible loops in LigT and the 2H family. A. Superposition of LigT crystal structures in this study (see
Fig 3 for colouring details). The three loops marked by arrows present different conformations in the crystal
structures; in addition the labeled amino acids differ in conformation between structures. B. Superposition of
the structural homologues identified in the Salami search. LigT is red. The 3 flexible loops, showing the largest
differences between these 2H enzymes, are highlighted by arrows. Orientation corresponds to the one in A.
C. The loops surrounding the active site in LigT show highest B factors, i.e. highest mobility. D. One of the
loops also shows specifically high B factors in CNPase. E. RMSF (black) of LigT residues during a 260-ns MD
simulation and crystallographic B factors (red) of LigT (left) and the structure of LigT coloured based on the
RMSF (right) indicate that the loops lining the active site are the most flexible segments of the enzyme. Red
colour on the structure indicates highest RMSF values.
doi:10.1371/journal.pone.0170355.g005
2H enzyme active site structure
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The dynamics of LigT were also studied using MD simulations. Analysis of the root mean
square fluctuations (RMSF) during the simulation (Fig 5E) indicates that the most dynamic
segments of the protein correspond to the loops described above, surrounding the active-site
cavity. The most dynamic structure appears to be the β hairpin formed between the two C-ter-
minal β strands; interestingly, this hairpin loop is not present in the mammalian CNPase struc-
ture. Some loops are more rigid in the simulation than predicted by the crystallographic B
factors; this observation may be related to the fact that the reaction product 20-AMP was pres-
ent in the active site in the simulation run. The results further highlight the flexible nature of
the loops, likely to play roles in LigT substrate binding.
Structure in solution
To obtain an insight into larger ligand binding, we carried out small-angle X-ray scattering
(SAXS) experiments with samples of LigT and yeast tRNA (Fig 6, Table 2). LigT was mono-
meric in solution, and the obtained 3D shape corresponded closely to that seen in the crystal
structure (Chi2 = 0.8 between experimental SAXS data and calculated data from a LigT mono-
mer). An exception was the highest concentration (>15 mg/ml), which fitted well to a dimeric
species; the relevance of this dimerization is not known, and we believe it was an artifact of the
very high concentration. tRNA is slightly larger and more elongated than LigT, as expected. A
Fig 6. SAXS analysis of LigT. A. Scattering curves of LigT (green), dimeric LigT (blue), yeast tRNA (red), and
the LigT-tRNA complex (black). The curves have been vertically displaced for easier viewing. B. Guinier plots of
all samples indicate clear lack of aggregation. Plots are shown for 0.5 < sRg < 1.3 for each sample. C. Distance
distributions. Note the clear shift of the main peak in the complex sample, indicative of complex formation. D.
SAXS-based models of monomeric LigT (top, green) and dimeric LigT (middle, blue). E. Models for the LigT-
tRNA complex. Left: The MONSA model is shown as spheres (LigT, green; tRNA, orange), and the crystal
structures of LigT and tRNA (PDB entry 2TRA [28]) are superimposed on the model. Right: SASREF rigid body
model with the same colouring. Fitting parameters of the models are given in Table 2. F. Fit of the complex
models in panel E to the experimental data. Top, MONSA; bottom, SASREF.
doi:10.1371/journal.pone.0170355.g006
2H enzyme active site structure
PLOS ONE | DOI:10.1371/journal.pone.0170355 January 31, 2017 9 / 17
multiphase ab initio modeling approach, taking advantage of the different X-ray scattering
properties of RNA and protein, based on SAXS data from the complex and both components
alone was employed, and an elongated complex (Fig 6C) fit the experimental data well. The
result is a clear indication of the ability of LigT to bind RNA molecules, in this case specifically
tRNA. Furthermore, the good fit of the 1:1 complex to the experimental data and the volume
of the corresponding ab initio model both imply that the sample was mostly in complex form,
with free LigT and tRNA not interfering with SAXS analysis. Whether tRNA would be a true
biological substrate or ligand for LigT, is unclear at present, and remains a subject for future
work. The fact that tRNA was not observed in the crystal structure can be explained by the
commercial yeast tRNA preparation being a mixture of different tRNAs, not homogeneous
enough to support crystallization of the complex.
Surface properties for RNA binding
Some viral and eukaryotic 2H enzymes cleave the 20-50-phosphodiester bond of 20-50-polyadeny-
lates [11–13]. Structural data [29] from these enzymes incidate that the 20,50-adenosine bispho-
phate substrate binds along the opposite side of the active site, compared to LigT and CNPase
(Fig 7A). In CNPase, the side used for 20,50-adenosine bisphophate in these enzymes is blocked
by the α7 helix, which coordinates the nucleophilic water. In LigT, this opposite side is open,
and there would be room for a larger nucleophile than water, even though recent data suggest
that short RNA molecules would not act as nucleophiles in LigT [22]. The central phosphate
moiety sits nearly identically on top of the HxTx motifs, however. Combining both binding
modes by superposition, interesting conservation can be observed (Fig 7A). For example, LigT
Trp82 is in a perfect position to stack against a base, and Arg120 is conserved. In the NADP+
complex, we actually observe unidentified electron density of a stacking interaction, modeled as
a fragment of NADP+, on top of Trp82, which could reflect low-affinity binding of some moiety
in NADP+. These observations highlight several possible sites for interaction between phos-
phate, sugar, and base moieties in RNA with residues lining the active-site groove in LigT.
LigT has been characterized as an enzyme that can ligate tRNA fragments cleaved by yeast
endonuclease. The ligation joins the 20,30-cyclic phosphate and 50-hydroxyl termini in a 20-50
phosphodiester linkage, where the linking phosphate group is derived from the cyclic phos-
phate moiety [10]. Therefore, LigT should bind RNA in the close vicinity of its active site. We
looked at the surface properties of LigT to better understand this process.
Earlier, we identified a possible RNA-binding groove in mouse CNPase, which additionally
has a polynucleotide kinase-like domain [17]. The surface analysis of LigT, specifically looking
at electrostatics, aromatic surface residues, and basic residues, indicates that a similar surface
extends away from the LigT active site. The active site is formed at the bottom of a groove
Table 2. Results from SAXS analysis.
Sample MW (kDa) Rg (nm) Dmax (nm) Chi
2
LigT dimer 34.5 2.60 ± 0.01 11 1.8 (GASBOR)
LigT monomer 23 1.98 ± 0.07 9 0.6 (GASBOR)
crystal* 19.8 1.83 5.6 0.8 (CRYSOL)
yeast tRNA 88** 2.66 ± 0.04 15 0.7 (DAMMIN)
LigT-tRNA 129** 3.32 ± 0.04 13 1.1 (MONSA); 2.5 (SASREF)
* values and fits for a monomer crystal structure
** Not reliable, as the MW was determined against a protein standard, and RNA has much higher scattering power than protein. Note, however, that the
complex MW corresponds to the sum of the individual components.
doi:10.1371/journal.pone.0170355.t002
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lined with basic and aromatic residues, and this groove has a very high positive electrostatic
potential (Fig 7B and 7C). These characteristics fit well to the hypothesis of RNA binding.
The substrate of LigT in an RNA ligation reaction is an RNA molecule, for which the 30-ter-
minal residue, with a 20,30-cyclic phosphate group, sits in the active site. The orientation of the
reaction products 20-AMP and NADP+ in the active site indicates the direction, into which an
RNA molecule would continue, considering the last residue sits in the active site. Likely partic-
ipants in RNA binding include several aromatic and Arg residues lining the active-site groove.
As the different structures predicted an RNA-binding surface on LigT, we further modeled
a 3-residue RNA molecule with a terminal 20-phosphate into the active site. Possible RNA rec-
ognition features can be deduced from this model (Fig 7D), which fit to the binding determi-
nants observed for different ligands crystallographically. The predicted binding mode includes
both electrostatic interactions between Arg residues and the phospho groups, stacking of bases
against aromatic residues, and C-H. . .π interactions of the ribose rings.
The possible functions of LigT
The 20-50 phosphodiester linkage between RNA nucleotides is apparently rare, but is neverthe-
less found all across biology. In animals, 2-5As synthesized by 20-50-oligoadenylate synthases
Fig 7. Evidence for an RNA binding surface from individual structures of nucleotide complexes. A.
Superimposed are the complexes of LigT (white) with 20-AMP (white), NADP+ (yellow), ATP (pink), and
phosphate (orange), as well as the complex of a viral RNase L agonist [29] with adenosine 20,50-bisphosphate
(green). All the ligands have a phosphate group in the active site, and superposition reveals other nearby
features for recognizing phosphate or aromatic base groups in RNA. Arrows indicate the different phosphate
binding sites, while red asterisks denote aromatic rings potentially involved in stacking of RNA bases. B.
Distribution of aromatic (orange) and basic (blue) groups in LigT. The catalytic site is indicated by the bound
reaction product 20-AMP. C. Surface electrostatic potential of LigT. The catalytic groove has a high positive
charge potential. D. Model of binding for a 3-residue RNA molecule with a 20-phospho group in the active site.
Yellow dashed lines indicate the polar contacts by the phosphate moieties. Also pay attention to stacking of
bases against Phe8, Phe159, and Arg86. Note Arg120 has flipped over to interact with the active-site
phosphate, when the model was energy-minimized and subjected to a short MD simulation.
doi:10.1371/journal.pone.0170355.g007
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have functions in innate immunity, whereby they specifically activate RNase L [30]. RNase L
then cleaves singe-stranded viral or cellular RNAs. 2-5As can also have antibacterial activity
[31]. Some viruses produce an enzyme that degrades 20-50-linked oligoadenylates and prevents
the activation of RNase L [13,32]. 20-50 oligoadenylates have also been detected in E. coli. The
level of these oligoadenylates increased as a response to phage infection, similarly to animals
[20]. Bacterial oligoadenylates are apparently adequate to activate RNase L, since the overex-
pression of recombinant mammalian nuclease resulted in RNA degradation and cell growth
inhibition [33]. LigT might function in the metabolism of bacterial 2-5As [20].
The original paper describing LigT identified it as having enzymatic activity resembling
tRNA ligases [10]. These activities included the 30-phosphodiesterase activity towards the 20,30-
cyclic phosphate present in the 30-terminus of the 50-half of the cleaved tRNA molecule, and
the subsequent ligation of the 30 and 50 halves with a 20-50-phosphodiester bond between the
20-phosphate group formed in the previous reaction and the 50-hydroxyl group of the 30-half of
the cleaved tRNA molecule [10]. The ligation was later found to be reversible, as the enzyme
additionally functions as a 20-50-phosphodiesterase [3,9]. Recently, however, concomitant with
the publication of the first E. coli LigT structure, this view was challenged, as LigT did not
appear to ligate short 10-nucleotide RNA oligomers with 20,30-cyclic phosphate and 50-
hydroxyl ends, but only acted on the cyclic phosphate [22]. Thus, LigT was claimed to be a
CNPase rather that RNA ligase. It should be noted that the experimental conditions in the dif-
ferent studies varied, and it is hard to draw a definite conclusion at this point. Our structural
data do highlight close structural similarities of bacterial LigT to RNA ligases and clear differ-
ences with respect to the vertebrate CNPase active site.
Despite the current lack of identity of the physiological activity of LigT, the crystal struc-
tures presented here further highlight the versatility of the active-site architectures in 2H phos-
phoesterases. The best-characterized 2H enzyme is mammalian myelin CNPase, for which a
central role in the reaction mechanism is played by the N terminus of helix α7 [17]. This helix
is missing in most 2H family members, including LigT, and therefore, the reaction mecha-
nisms must also be different across the enzyme family. The α7 helix blocks access of larger
nucleophiles than water into the CNPase active site, and it could be argued that its absence in




Genomic DNA from the BL21(DE3) strain of E. coli was purified and used as a template for
PCR (S1 Table). The initial primers for the first PCR added a TEV cleavage site to the N termi-
nus of the coded protein sequence. A second PCR reaction added attB cloning sites to both
ends of the insert. The product from the latter reaction was subcloned into the pDONR221
vector (Invitrogen) and further subcloned into the pTH27 expression vector [34], which adds
an N-terminal His6 tag to the expression product. Clones were verified by DNA sequencing
and found to be identical with the LigT database entry (Genbank id. AM946981.2).
Expression and purification
LigT was overexpressed in the BL21(DE3) strain using ZYM-5052 autoinduction medium
[35], supplemented with 100 μg/ml ampicillin and 0.01% Antifoam 204 (Sigma). The expres-
sion culture was incubated at +37˚C for 24 h. Overexpression did not lead to any obvious toxic
effects. The dry cell weight was around 12 g for 1 liter of culture. Cells were harvested by cen-
trifugation and resuspended in lysis buffer containing 50 mM Na-HEPES (pH 7.5), 500 mM
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NaCl, 20 mM imidazole, 0.5 mM TCEP, and 1x EDTA-free protease inhibitor (Roche). The
suspension was flash-frozen in liquid nitrogen and stored at -70˚C until use.
The cell suspension was supplemented with 0.1 mg/ml lysozyme and sonicated. The lysate
was clarified by a 30-min centrifugation at 27000 g. The clarified lysate was then mixed with
Ni-NTA (Qiagen) matrix. The matrix was washed with lysis buffer, and the protein was eluted
from the matrix with elution buffer containing 500 mM imidazole. Fractions were analysed
using SDS-PAGE. His-tagged TEV protease [36] was added to the eluted fractions containing
LigT, in order to remove the His6 tag, and this mixture was dialyzed overnight against lysis
buffer devoid of imidazole. The dialyzed sample was passed through the Ni-NTA matrix to
remove TEV protease, uncleaved LigT, and any other Ni-NTA binding contaminants. The
eluted fractions were analyzed using SDS-PAGE. Fractions with cleaved LigT were concen-
trated and applied to a Superdex 75 16/60 (GE Healthcare) size exclusion chromatography col-
umn equilibrated with 10 mM Na-HEPES (pH 7.5), 100 mM NaCl, and 0.5 mM TCEP.
Fractions were analysed using SDS-PAGE, and the fractions containing pure LigT were
pooled. Approximately 25 mg of pure protein was obtained from one liter of expression cul-
ture. Pure LigT was flash-frozen in small batches with liquid nitrogen and stored at -70˚C until
use.
Crystallization and data collection
For crystallization, LigT was in the gel filtration buffer at 10 mg/ml. Sitting drop crystallization
experiments were prepared with 2:1, 1:1, and 1:2 drop ratios. The crystallization conditions
were composed of 0.1 M Tris-HCl at pH 7.4–7.5, 0.2 M MgCl2, and PEG 8000 at 12–20% (w/
v). For obtaining liganded complexes, LigT was mixed with putative active-site ligands prior to
crystallization at 5 mM ligand concentration; these compounds included ATP, NADP+, 20,30-
cAMP, and 30-AMP. Crystals were cryoprotected by soaking them for a few minutes in the
well solution supplemented with the ligand (if present) and 15% (v/v) PEG 200. X-ray diffrac-
tion data were collected using synchrotron radiation at 100 K. Data were collected on beam-
lines P11 and P13 [37] at PETRA III/DESY (Hamburg, Germany), as well as on beamline
I911-2 at MAX-Lab (Lund, Sweden). All data were processed using XDS [38].
Structure solution and refinement
At the time of these experiments, the bacterial LigT structure had not been solved. The struc-
ture was solved here by molecular replacement with PHASER [39] using as a search model the
LigT orthologue structure from Thermus thermophilus [40] (PDB entry 1IUH, sequence iden-
tity 28%), modified with phenix.sculptor [41] to resemble more closely the target sequence.
Refinement was carried out in phenix.refine [42] and rebuilding in COOT [43]. Final struc-
tures were validated using MolProbity [44]. Coordinates and structure factors were deposited
at the PDB under accession codes 5LDI (apo), 5LDJ (phosphate complex), 5LDK (ATP com-
plex), 5LDM (20-AMP complex), 5LDO (30-AMP complex), 5LDP (ATP complex 2), and
5LDQ (NADP+ complex).
Structure analysis
Structural sequence alignments were done with Swiss PDB Viewer [45] and Espript [46]. For
structure analyses, PyMOL and UCSF Chimera [47] were used. Superpositions were done with
the SSM algorithm [48], and structural homologues were searched using Salami [49]. Model-
ing of the substrate complex and a complex with a 3-base RNA oligonucleotide was done in
YASARA [50]. Electrostatic surfaces were calculated using PDB2PQR and ABPS [51].
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Molecular dynamics simulations
The complex of LigT with the bound product 2’-AMP was subjected to MD simulations with
the program YASARA [50], version 16.2.21. The structure was placed in a cubic box filled with
water, the pH was kept at 7.4, and NaCl was added to keep the salt concentration at the physio-
logical 0.9% (w/w). After initial energy minimization, an MD run of 260 ns was carried out at
298 K. The default YASARA settings were used, saving snapshots every 250 ps, and employing
the AMBER14 force field. YASARA scripts were further used for simulation data analysis.
Small-angle X-ray scattering
SAXS data were collected in batch mode on the EMBL/DESY synchrotron beamline P12 [52],
using standard procedures [53]. In addition to LigT alone, yeast tRNA (Sigma) and a 1:1 molar
mixture of LigT and tRNA were analyzed. Data were processed with the ATSAS package [54].
Distance distribution functions were analyzed using GNOM [55]. For modelling LigT alone,
GASBOR [56] was used. For modelling the protein-RNA complex, we used the program
MONSA [57] with the protein and RNA in different phases. The tRNA alone was modelled
using DAMMIN [57]. Molecular weight was estimated through a comparison of the forward
scattering intensity of the sample to that of a fresh sample of monomeric bovine serum
albumin.
Isothermal titration calorimetry
ITC was carried out using an iTC200 instrument (Microcal). In brief, 0.2–0.4 mM LigT was
titrated with 5–10 mM ligand (20-AMP, 30-AMP, ATP, NADP+); both the protein and ligand
were in a buffer consisting of 10 mM HEPES (pH 7.5), 0.2 M NaCl, and 0.1 mM TCEP. The
titration was carried out at +25˚C, and the data were analysed using MicroCal Origin.
Supporting information
S1 Table. Primers used for LigT cloning.
(DOCX)
S1 Fig. ITC analysis of nucleotide binding by LigT.
(PDF)
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